| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |